NexCure Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $19M

  • Investors
  • 3

NexCure General Information

Description

Operator of outpatient oncology treatment centers intended to expand access to advanced cellular and radiopharmaceutical therapies. The Company partners with health systems to build and operate specialized outpatient treatment centers focused on delivering therapies such as CAR-T and T-cell engager treatments, enabling cancer patients access advanced therapies closer to home through specialized outpatient treatment centers.

Contact Information

Website
www.nexcure.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 200 Berkeley Street, 18th Floor
  • Boston, MA 02116
  • United States
Primary Industry
Clinics/Outpatient Services
Vertical(s)
Corporate Office
  • 200 Berkeley Street, 18th Floor
  • Boston, MA 02116
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NexCure Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 03-Feb-2026 $19M Completed Generating Revenue
1. Seed Round Completed Generating Revenue
To view NexCure’s complete valuation and funding history, request access »

NexCure Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed
To view NexCure’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

NexCure Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cencora Ventures Corporate Venture Capital Minority
Oncology Ventures Venture Capital Minority
RA Capital Management Asset Manager Minority
To view NexCure’s complete investors history, request access »

NexCure FAQs

  • When was NexCure founded?

    NexCure was founded in 2024.

  • Where is NexCure headquartered?

    NexCure is headquartered in Boston, MA.

  • What industry is NexCure in?

    NexCure’s primary industry is Clinics/Outpatient Services.

  • Is NexCure a private or public company?

    NexCure is a Private company.

  • What is the current valuation of NexCure?

    The current valuation of NexCure is .

  • What is NexCure’s current revenue?

    The current revenue for NexCure is .

  • How much funding has NexCure raised over time?

    NexCure has raised $22M.

  • Who are NexCure’s investors?

    Cencora Ventures, Oncology Ventures, and RA Capital Management have invested in NexCure.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process